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ABSTRACT
Microarrays to examine the global expression levels
of microRNAs (miRNAs) in a systematic in-parallel
manner have become important tools to help
unravel the functions of miRNAs and to understand
their roles in RNA-based regulation and their
implications in human diseases. We have estab-
lished a novel miRNA-specific microarray platform
that enables the simultaneous expression analysis
of both known and predicted miRNAs obtained
from human or mouse origin. Chemically modified
20-O-(2-methoxyethyl)-(MOE) oligoribonucleotide
probes were arrayed onto Evanescent Resonance
(ER) microchips by robotic spotting. Supplementing
the complementary probes against miRNAs with
carefully designed mismatch controls allowed for
accurate sequence-specific determination of
miRNA expression profiles obtained from a panel
of mouse tissues. This revealed new expression
signatures of known miRNAs as well as of novel
miRNAs previously predicted using bioinformatic
methods. Systematic confirmation of the array data
with northern blotting and, in particular, real-time
PCR suggests that the described microarray plat-
form is a powerful tool to analyze miRNA expression
patterns with rapid throughput and high fidelity.
INTRODUCTION
miRNAs play important roles in a variety of physiological
processes (1–6). Determination of spatial and temporal
expression of miRNAs is a useful means to gain insight
into the function of these small biomolecules. Northern
blot analysis and molecular cloning strategies have been
frequently used to determine approximate miRNA
expression levels in biological samples (7–12).
Recently, more quantitative methodologies such as the
Invader assay (13), bead-based hybridization assays (14)
and RT-PCR assays (15–19) have been developed.
The number of experimentally veriﬁed miRNAs is
continuously growing and it is predicted that the total
number of mammalian miRNAs will be in excess of more
than a thousand (3), possibly tens of thousands (20).
It is likely that microarrays will become the method of
choice for global miRNA proﬁling studies since they are
able to screen large numbers of molecules simultaneously
and allow for ﬂexible probe design. Due to the short
length of miRNAs, the principle challenge in the
generation of microarray-based miRNA assays is the
optimization of hybridization conditions that oﬀer max-
imal binding aﬃnity without compromising speciﬁcity.
Most miRNA array platforms that have been described
to date make use of DNA-oligonucleotides as capture
probes (21–28). However, several nucleic acid analogs
have emerged over the last years that demonstrate more
favorable hybridization characteristics as compared to
standard DNA-based probes. Some of the analogs,
including peptide nucleic acids (PNA) (29) and locked
nucleic acids (LNA) (30), have been used on classical
mRNA microarrays. Recently, Castoldi et al. have
described the application of mixed LNA/DNA-modiﬁed
capture probes in array-based proﬁling of miRNAs and
have reported superior sensitivity over conventional
DNA-based miRNA arrays (31). From a technical point
of view, one of the most amenable oligonucleotide
 To whom correspondence should be addressed. Tel: þ49-613246142; Fax: þ41-61-3242217; Email: jan.weiler@novartis.com
Correspondence may also be addressed to Witold Filipowicz. Tel: þ41-616974128; Fax: þ41-61-6973976; E-mail: witold.filipowicz@fmi.ch
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors.
Present address:
Fabrice A. Kolb, Protease Platform, Novartis Institutes for Biomedical Research, CH-4002 Basel, Switzerland
Jonathan Hall, Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH) Zurich, Switzerland
 2007 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.modiﬁcations comprises chemical manipulations
at the 20-position of the ribose. In particular, the
20-O-(2-methoxyethyl)-(MOE) moiety (Figure 1), which
has been the subject of extensive research in antisense-
based technology, was shown to bind with high aﬃnity
and speciﬁcity to natural RNA (32,33). These properties
encouraged us to apply MOE-modiﬁed oligoribonucleo-
tides as capture probes for the microarray-based detection
of miRNAs. We have recently introduced a novel
generation of microchips that rely on evanescent resonator
(ER) technology which have shown improved sensitivity
in mRNA expression experiments when compared with
conventional microarrays due to their unique optical
features (34).
In this article, we describe a miRNA microarray which
combines the advantages of ER-based microarray detec-
tion with the favorable properties of MOE-oligoribo-
nucleotide as capture probes. The MOE-probes were
arranged on the ER-microarrays by robotic spotting
which results in a ﬂexible platform which can be rapidly
updated in order to deal with newly identiﬁed validated or
predicted miRNA candidates. Extensive validation studies
were performed by comparing miRNA array data
generated from human cell lines and mice tissues with
conventional Northern blots as well as semi-quantitative
RT-PCR. miRNA expression proﬁles obtained with the
MOE-ER array revealed novel signatures for several
known miRNAs as well as for computationally predicted
miRNAs, demonstrating the suitability of this novel
microarray platform for robust high-throughput analysis
of miRNA expression.
MATERIAL AND METHODS
Design andsynthesis of MOE oligonucleotides
MOE capture probes were designed for 200 human or
mouse miRNAs including 50 miRNAs that have been
predicted in silico but not experimentally conﬁrmed yet
(35). The length of these miRNAs varies from 20 to 24
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Figure 1. Structure of chemically modiﬁed 20-O-MOE-RNA compared with natural RNA.
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employed to identify miRNAs often cannot precisely
deﬁne the 50 and 30 extremities of the miRNA, the MOE
capture probes were complementary to the central 19 nts
of the miRNA. For 20-nt-long miRNAs, the capture
probe was complementary to 19 50-proximal nucleotides
of the miRNA, for 21-nt-long and longer miRNAs, the
capture probes were complementary to nucleotides 2–20
of the miRNA.
For each perfectly matched (0MM) probe, single nt
mismatch (1MM) control oligomers were designed by
replacing an existing base at a non-terminal position
by applying one of the four base permutation rules:
A!C, C!A, U!Go rG !U. To avoid cross-
matches of the controls, we aligned all probe sequences
to all non-parental miRNA probes using the Smith–
Waterman algorithm from the FASTA 3.4 suite (expect
value¼20, ungapped, both strands, base scoring þ5/ 4.
G–U base pairs were not considered as mismatches but as
a partial match with positive contribution of þ2 to the
score). The position of the mismatch was initially central
(base number 10) and the smallest cross-match distance
was extracted. The replacement position was then
gradually shifted out of the center towards the ends and
the homology search was repeated in order to identify a
position of the replacement which increases the distance of
the probe from the closest non-parental miRNA sequence.
Terminal positions (1,19) were not selected by the
algorithm. An additional 2nt mismatch (2MM) control
oligomer was generated for each accepted 1MM control
sequence by changing a second base using the same
algorithm. 20-MOE-modiﬁed oligonucleotides were pre-
pared as described elsewhere (36).
Cell culture
Human HeLa cells were grown at 378C in Dulbecco’s
modiﬁed Eagle’s medium supplemented with 10% FCS
and 2mM L-Glutamine.
Preparation of labeledmiRNAs from human HeLa cells or
mouse organs
According to the protocols provided by the manufacturer,
approximately 1.5 10
7 cells were washed with PBS
and total RNA was isolated using Trizol Reagent
(Life-TechnologiesTM, cat no: 15596-018) and genomic
DNA potentially present in the RNA fraction was
digested using RNase-free DNase I (Ambion, cat no:
2222). Following phenol/chloroform extraction, total
RNA was ethanol precipitated, resuspended in RNase-
free water and 100mg of RNA was applied to a RNeasy
mini spin column (Qiagen, cat no: 74104)
following the RNA cleanup protocol of the manufacturer.
The RNA-species smaller than  200 nts contained in the
ﬂow through were ethanol-precipitated, resuspended in
RNase-free water. The amount of recovered RNA was
estimated by measuring optical density at 260nm.
Mouse organs were collected from 0.9% perfused
18-week-old BL6 male mice. The organs were homogenized
in the presence of Trizol (1ml Trizol/100mg tissue)
using a polytron homogenizer. RNA recovery and DNA
digestion was performed as described above.
MiRNAs present in the column puriﬁed RNA fraction
were labeled by incorporation of a single Cy5 label
at the 30-end of RNA molecules as described by
Garnier et al. (37). In brief, 9mg RNA dissolved in 9ml
RNase-free water was oxidized to dialdehyde by
adding 1ml freshly prepared 100mM sodium periodate
followed by an 1h incubation at room temperature in the
dark. Excess of oxidant was removed by adding 1mlo f
a 200mM solution of sodium sulﬁte and incubation for
20min at room temperature. After adding 12mlo f5 0m M
sodium acetate buﬀer (pH 4), 5ml of 20mM ethylenedia-
mine hydrochloride (pH 7.2) was added to the oxidized
RNA. The reaction mixture was incubated for 1h at 378C,
and the aldimine bond between the RNA and the spacer
was reduced with 2ml freshly prepared 200mM sodium
cyanoborohydride in acetonitrile. The mixture was incu-
bated for 30min at room temperature and precipitation
was eﬀected with 2 volumes of 2% lithium perchlorate in
acetone for 1h at 08C. The sample was spun at 14 000rpm
for 45min at 48C and, after removal of the supernatant,
the RNA pellet was washed twice with acetone and air
dried. Conjugation was carried out by resuspending the
amino-modiﬁed RNA in 5ml DEPC-treated water and
adding 5ml of 30mM Cy5N-hydroxysuccinimidyl active
ester in 1M sodium phosphate buﬀer (pH 7.8).
After incubation for 1h at room temperature in the
dark, the RNA was precipitated with 2.5 volumes of 100%
ice-cold ethanol for 1h at  208C. The sample was spun
at 14 000rpm for 30min at 48C and after removal of
supernatant, the Cy5-RNA pellet was washed twice
with ice-cold 70% aqueous ethanol and air dried.
Labeled RNA was quantiﬁed by measuring optical density
at 260nm.
Preparation ofmicroarrays
The ER microchip transducers (dimensions 25 75mm)
were manufactured by Unaxis AG, Liechtenstein, accord-
ing to speciﬁcations described elsewhere (38). Glass slides
were nanostructured in order to create a fully corrugated
surface (grating period 360nm). Subsequently, the corru-
gated surface was coated with Ta2O5 as dielectric material
(150nm thickness, refractive index material n¼2.1).
Chips were printed essentially as described (34,38).
Brieﬂy, MOE-oligomer probes were spotted as 10mM
solutions in 4 SCC containing 0.001% Sarcosyl in
quadruplicates on the chip surface. A MicroGrid
Arrayer (Genomic Solutions, Inc.) equipped with SMP
3 pins (Telechem, Inc.) was used for the production of the
microarrays. The dimensions of the printed area were
approximately 2cm
2. Printing was carried out at 238C
at humidity adjusted to 55–60%. A Tecan LS scanner in
scatter mode (red laser excitation, ﬂuorescence ﬁlter
removed) was used to check the presence of the spots
printed as quality control.
Hybridization andscanning
An HS 4800 Hybridization station from Tecan, Inc.
was used for the hybridization of microarrays.
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with washbuﬀer (WB) containing 20mM Na-phosphate
pH 6.5 (499%, Merck), 50mM NaCl ( 99.5%, Fluka),
1mM EDTA (Invitrogen) and 0.1% (w/v) SDS (Fluka),
each wash for 20s at 758C, followed by two washes for
20s with WB at 508C.
Typically, 0.15–8.0mg size-fractionated HeLa RNA
and 2mg size-fractionated mouse organ RNA dissolved
in 100ml hybridization buﬀer [70% (v/v) ExpressHyb
(Clontech BD, cat no: 8015-1) in formamide (Fluka, cat
no: 47671) containing 100mg/ml sonicated salmon sperm
DNA (Stratagene)] was injected into the ﬂow chambers
in liquid phase at 508C and the samples were agitated at
the same temperature for one minute. The temperature
was then increased to 758C (for 10min) to denature
any hybridized strands. Subsequently, the temperature
was adjusted to 528C and hybridization was carried
out for 16h with agitation. A post-wash consisted of
four 20s washes with WB at 528C followed by an
additional wash at 238C. Finally the slides were washed
three times with WB, dried under a stream of N2, and
scanned immediately with an unmodiﬁed Agilent LS
ﬂuorescence scanner (gain 80%). An external spike was
used as landing mark for the grid alignment and could
be optionally used as control for the hybridization
experiments.
Image analysis
The ﬂuorescence images were analyzed by means of Array
Pro (Mediacybernetics, Inc. US). Net signals were
calculated by subtracting the local background ring
median from trimmed mean of each spot (20% trimming
on both sides of the intensity histogram). Typically,
the data represent a mean value of the quadruplicates
printed for each sequence onto the slides. No normal-
ization was employed. Contaminated spots were manually
excluded from analysis, in such cases the mean value
was based on less than four spots. Raw data were analyzed
in GENESPRING software, version 7.0 (Agilent
Technologies/Silicon Genetics, Redwood City, CA). The
observed mean background standard deviation was
typically approximately 15 counts (cts). In general,
miRNAs were considered as absent if the ﬂuorescence
intensity of the perfectly matched probe was not 2-fold
higher than the mean background ﬂuorescence.
A particular miRNA was considered as present if the
ﬂuorescence intensity from the perfectly matched probe
was found to be greater than the corresponding 1 and
2MM control probes.
Northern blotting
Mir-141 (50-ccatctttaccagacagtgtta-30), mir-194 (50-tccacat-
ggagttgctgttaca-30), mir-31 (50-cagctatgccagcatcttgcct-30),
mir-215 (50-gtctgtcaaatcataggtcta-30) probes were labeled
with [-
32P]ATP (MP Biomedicals, 7000Ci/mmole) and
T4 polynucleotide kinase (New Englands Biolabs). Pir-5/
mir-499 (50-ttaaacatca-ctgcaagtcttaa-30) and U6 snRNA
(50-gccatgctaatcttctctgta-tc-30) probes were 50-digoxigenin-
labeled. All probes were obtained from Microsynth
GmbH.
For Northern analysis, 5–30mg of total tissue RNA was
separated on denaturing 15% polyacrylamide/7M urea
gels run in TBE and transferred to Hybond
Nþmembranes (Amersham) in TBE using semi-dry
conditions (Biorad). After UV-cross-linking at 120 mJ,
the membranes were equilibrated for 1h at 378C in 0.75M
NaCl, 3.75mM Na2EDTA, 50mM NaH2PO4 (pH 7.4),
supplemented with 0.04% Ficoll Type 400, 0.04%
polyvinlylpyrrolidone, 0.04% BSA, 20mg/ml salmon
sperm DNA and 4mg/ml yeast tRNA.
32P-labeled probes
were hybridized to the membranes over-night at 378Ci n
the above buﬀer. After washing of the membranes for
10min in 2 SSC containing 0.1% SDS, 30min in
0.1 SSC containing 0.1% SDS and 5min in 2 SSC,
radioactivity was analyzed using a Storm 860
PhosphorImager (Molecular Dynamics). Northern blots
hybridized with digoxigenin-labeled probes were washed,
blocked with blocking solution (Roche, cat no: 1585762)
and incubated with an alkaline phosphatase conjugated
anti-digoxigenin antibody (Roche, cat no: 1093274)
according to the manufacturer’s protocol. Membranes
were incubated in ready-to-use CDP-Star (Roche, cat no:
2041677) and chemiluminescense was detected using the
ChemiDoc XRS (BioRad).
miRNA stem-loop Real-Time PCR analysis
Quantiﬁcation of miRNAs by TaqMan Real-Time PCR
was carried out as described by the manufacturer (Applied
Biosystems). Brieﬂy, 0.1–1ng of template RNA was
reverse transcribed using stem-loop primer (ABI, cat no:
4365409) high capacity cDNA Archive Kit (ABI, cat no:
4322171) and RNAase inhibitor (ABI, cat no: N8080119).
The 15ml reactions were incubated in a thermocycler
(Applied Biosystems 9800) in 96-well plates for 30min
at 168C, 30min at 428C, 5min at 858C and then held
at 48C.
For the PCR reaction, 2ml of RT-product, equivalent
to approximately 0.13ng total RNA, was mixed with the
Universal PCR Master mix (ABI, cat no: 4324018) and
the TaqMan MicroRNA Assay Human Panel (ABI, cat
no: 4365409). The reactions were incubated in 96-well
plates on the Applied Biosystems 7500 FAST Sequence
Detection System at 958C for 10min, followed by
40 cycles of 958C for 15s and 608C for 1min. An assay
speciﬁc for an Arabidopsis thaliana miRNA (ath-mir159A)
and two assays speciﬁc for Caenorhabditis elegans
miRNAs (Cel-miR-2 and Cel-lin-4) were used as negative
controls. If not indicated otherwise, both RT- and PCR-
reactions were performed in duplicate. miRNAs were
considered as present when Ct-values (TaqMan threshold
cycle) were lower than 34.
RESULTS AND DISCUSSION
miRNA array design
MOE oligonucleotides to 150 human and mouse miRNAs
were designed to perfectly complement miRNA sequences
deposited in the miRNA Registry Database (39,40). In
addition, we designed oligomer probes complementary
to 50 predicted putative mammalian miRNAs for which
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miRNA-unrelated MOE oligonucleotides as internal
controls. One of the critical issues in short-oligomer
microarray technology is the occurrence of false positive
signals due to cross-hybridization of surface-bound probes
with highly homologous miRNAs belonging to the same
family and other non-target-related RNA sequences.
In order to address this problem, we designed for each
perfect matched probe (0MM) two additional mismatched
probes containing one (1MM) and two (2MM)
mismatches placed close to the center of the sequence.
The puriﬁed MOE oligoribonucleotides containing no
additional modiﬁcations were directly deposited onto
the silanized ER slides by robotic pin printing.
miRNA expression profilingin human HeLa cells andmouse
organs
In order to label the miRNA population in a complex
RNA sample, we have adapted a chemical labeling
technique (37) allowing for the incorporation of Cy5at
the 30-terminus of RNA. Since this approach requires an
intact 20,30-diol terminus, background signals due to cross-
hybridization with contaminant RNA species bearing
30-phosphate groups or DNA can be minimized. An added
beneﬁt of this labeling method is that it does not require
enzymatic or ampliﬁcation steps that bear the danger
of modifying the original RNA sample content.
Hybridization conditions for miRNA proﬁling were
optimized by testing the eﬀects of hybridization conditions
and probe concentration using a panel of chemically
synthesized 30-end-labeled miRNAs (data not shown).
Subsequently, we investigated the performance of the
MOE-ER array platform when challenged with a complex
biological sample. For this, diﬀerent amounts of labeled
HeLa RNA were hybridized on the arrays. A dose
response and mismatch discrimination of ﬂuorescence
signals was obtained for the majority of the miRNAs as
exempliﬁed for mir-17-5p, mir-17-3p, mir-26a, mir-24,
mir-16 and mir-21 which represent miRNAs known to be
expressed in HeLa cells (7,41). miRNA signals were
considered as present if the ﬂuorescence intensity of
the perfectly matched probes was higher than that of the
corresponding mismatch probes, and if the perfectly
matched signal increased with increasing RNA concentra-
tion (Figure 2 and Supplementary Table S1). Importantly,
in most cases no to minimal signals were obtained with
the mismatch controls, demonstrating the speciﬁcity of the
MOE-ER array.
More recently, PCR-based methods have been
developed to assay quantitatively the abundance of
individual miRNAs (18,19,42,43). We compared the
expression levels of 107 miRNAs measured with the
MOE-ER array and with commercially available stem-
loop RT-PCR reagents (17,44), using HeLa RNA. Taking
into account that both methods have potential biases
and technical limitations, the expression data determined
by the MOE-ER array were in excellent agreement
with the results obtained by using RT-PCR (Table 1).
Applying 150ng size-fractionated HeLa RNA,  75%
from the miRNAs classiﬁed as present by the array
were conﬁrmed by the PCR. On the other hand,  75% of
miRNAs classiﬁed as absent in HeLa cells by the array
were also recorded negative by RT-PCR. For eight
miRNAs, a clear assignment was not possible since
the corresponding array signals did not match the
established speciﬁcity criteria. The discrepancies between
the two analysis methods may be caused by several
reasons. Due to the limited possibilities for miRNA probe
design, subjecting all probes to identical hybridization
conditions is a compromise which may lead to some
false negatives as well as false positives. Thus, the
‘absence’ of a speciﬁc signal on the array does not
necessarily imply that the miRNAs are not present in
the sample but may be due to the hybridization
signal not passing the arbitrary threshold value at the
applied experimental conditions. With two exceptions
(mir-137 and mir-140) in all instances where miRNAs
were clearly recorded by RT-PCR, they also became
detectable by the array when the amount of input
RNA was increased (Supplementary Table S1). The
cases when a miRNA was scored as positive on
the MOE-ER array but was not detected by RT-PCR
(mir-214, mir-185 and mir-146) may represent non-speciﬁc
hybridization of other cellular RNAs to the array
probes. These considerations emphasize the importance
of validating miRNA array data by an independent
method.
As a next step, we have used the MOE-array to deﬁne
new expression proﬁles of known miRNAs and also to
verify the existence and expression of bioinformatically
predicted miRNAs (complete data set in Supplementary
Table S2). RNA samples (5200nt) originating from eight
diﬀerent mouse organs were labeled and hybridized
individually to MOE-ER arrays. Approximately half
of the miRNAs represented on the array exhibited
a signiﬁcant expression in at least one tissue investigated,
with several miRNAs showing a strong enrichment
in some tissues (Figure 3). The tissue miRNA proﬁling
data obtained with the MOE-ER array were comparable
with the results obtained by other array-based
or unrelated methodologies (8,27,28,45–50) (see also
Supplementary Table S3). However, the MOE-array
data also revealed new information about expression
proﬁles of known miRNAs. Speciﬁcally, a small group of
known miRNAs, consisting of mir-31, mir-141, mir-194
and mir-215, was found to have elevated expression levels
in the small intestine. The expression proﬁles of
these miRNAs were also analyzed by Northern blot and
RT-PCR analysis (Figure 4). Intriguingly, comparable
relative expression patterns were obtained in all cases
independent of the method of analysis. The array
data correlates with Northern blot and RT-PCR in that
the four miRNAs (mir-141, mir-194, mir-31 and mir-215)
are found to be enriched in small intestine. These data
illustrate the exquisite selectivity of the MOE-ER meth-
odology. The stem-loop RT-PCR reagents used in the
present study have been demonstrated to eﬀectively
discriminate between mature miRNA and corresponding
primary and precursor miRNA (17). Since we could
demonstrate that the MOE-ER array data correlate very
PAGE 5 OF 11 Nucleic Acids Research, 2007, Vol. 35, No. 7 e52well with corresponding stem-loop PCR data (Figure 4)
we conclude that the array detects primarily the mature
miRNA. In addition, in the majority of cases investigated
here, Northern blot analysis was not able to detect signals
that could be clearly assigned to the pre-miRNA molecule.
This is in agreement with other reports (18,31) indicating
that for most miRNAs the steady-state level of the
precursor form is very low as compared to the mature
miRNA. In a recent study (51), the authors demonstrate,
using Northern blot analysis, that the mature form of mir-
138 is predominantly expressed in brain whereas mir-138
precursor is ubiquitously expressed. Interestingly, both the
Figure 2. Sensitivity and speciﬁcity of MOE-ER-based miRNA arrays. A dose response and mismatch (MM) discrimination of ﬂuorescence
signals was obtained for mir-17-5p, mir-17-3p,mir-26a, mir-24, mir-16 and mir-21 which represent miRNAs known to be expressed in HeLa cells.
MOE-ER arrays were probed with the indicated amounts of the size-fractionated (5200nt) Cy5-labeled HeLa cell RNA. Expression values for
all individual miRNA are shown in Supplementary Table S1.
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mir-138 is predominantly expressed in brain, supporting
the notion that the MOE-ER array mainly detects mature
miRNAs (Supplementary Figure S4). We speculate
that the thermodynamically stable hairpin structure of
the precursors makes them less available for array
probe hybridization.
In addition to known miRNA-probe sequences,
the microarray described here also carried probe sets
against a series of computationally-predicted (pir)
miRNAs (35). Seven of the putative miRNAs (pirs)
produced positive signals on the MOE-ER array
for which Northern blot analysis failed to detect a RNA
species corresponding to the expected size (data not
shown). Development of more sensitive assays, such as
RT-PCR, would be required to conﬁrm the authenticity of
these putative miRNAs.
From all the pirs represented on the MOE-ER array,
the most distinct expression pattern was obtained for
mmu-pir-5 having a strong expression in mouse heart
but no detectable expression in any other tissue tested.
The enrichment of pir-5 in heart was veriﬁed by Northern
blot analysis (Figure 5). During the course of this study,
Mineno et al. reported the existence of pir-5 in
whole mouse embryos and subsequently annotated it as
mmu-mir-499 (52). It would be of great interest to identify
the functional signiﬁcance of the heart-speciﬁc expression
of this miRNA.
CONCLUSIONS
In analogy to mRNA expression proﬁling studies,
approaches to systematically determine expression pat-
terns of miRNAs have the potential to rapidly accumulate
Table 1. Comparison of miRNA expression in HeLa cells recorded by MOE-ER array (150ng size-fractionated RNA) and stem-loop RT-PCR
methodology (15pg RNA per PCR reaction). miRNAs are ranked in the order of decreasing relative abundance as determined by RT-PCR (inverse
correlation with the threshold cycle (Ct) value). Ath-mir-159, cel-mir-2 and cel-lin4 miRNA RT-PCR assays were included as negative controls.
Signals considered as present are highlighted in bold. Values in italics depict cases where a clear assignment was not possible as the corresponding
array probe sets did not pass the established speciﬁcity criteria (n/a, not available)
miRNA ID PCR (Ct) Array (counts) miRNA ID PCR (Ct) Array (counts) miRNA ID PCR (Ct) Array (counts)
mir-21 23.5 362 mir-29b 30.5 23 mir-200a 40.0 9
mir-17-5p 25.9 565 let-7d 30.7 547 mir-146 40.0 66
mir-19a 26.1 61 mir-151 30.8 18 mir-154 40.0 7
mir-23a 26.3 2873 mir-181a 31.1 32 mir-197 40.0 23
mir-16 26.4 177 mir-30e 31.2 48 mir-199a 40.0 7
mir-20 26.7 455 mir-28 31.5 33 mir-9 40.0 3
mir-106a 26.8 432 mir-152 31.5 12 mir-141 40.0 4
mir-30b 27.1 125 mir-140 31.5 14 mir-223 40.0 3
mir-29c 27.1 61 mir-182 31.6 33 mir-134 40.0 9
mir-29a 27.1 319 mir-195 31.8 9 mir-219 40.0 2
mir-30c 27.3 327 mir-193 31.9 203 mir-200b 40.0 9
mir-100 27.5 492 let-7e 32.1 166 mir-129 40.0 3859
mir-15b 27.6 287 mir-132 32.2 234 mir-127 40.0 12
let-7i 27.6 2055 mir-10a 32.7 14 mir-142-5p 40.0 6
mir-23b 27.6 2175 mir-137 32.7 12 mir-9  40.0 2
let-7a 27.7 672 let-7b 33.0 192 mir-124a 40.0 254
mir-92 27.7 462 mir-107 33.7 111 mir-144 40.0 6
mir-99a 27.9 503 mir-155 34.0 0 mir-147 40.0 17
mir-27b 28.0 2091 mir-139 34.1 4 mir-150 40.0 8
mir-26a 28.2 106 mir-181c 34.1 15 mir-154 40.0 7
mir-31 28.2 646 mir-138 34.1 31 mir-184 40.0 0
let-7g 28.3 89 mir-149 34.1 14 mir-187 40.0 6
mir-130a 28.3 43 mir-203 34.1 5 mir-198 40.0 737
mir-224 28.6 72 mir-194 34.3 8 mir-205 40.0 18
mir-186 28.7 5 mir-213 34.5 11 mir-211 40.0 5
mir-145 28.7 35 mir-126 34.6 6 mir-216 40.0 1
mir-103 28.8 101 mir-148a 34.6 4 mir-220 40.0 8
mir-25 29.0 169 mir-214 35.0 132 ath-mir-159a 40.0 n/a
mir-26b 29.1 60 mir-133a 35.4 6 cel-mir-2 40.0 n/a
mir-221 29.2 131 mir-189 35.7 22 cel-lin-4 40.0 n/a
mir-27a 29.3 2928 mir-185 35.7 635
mir-181b 29.4 12 mir-199a  40.0 2
mir-130b 29.4 21 mir-199b 40.0 24
mir-125a 29.5 148 mir-218 40.0 46
mir-30d 29.5 185 mir-215 40.0 8
mir-191 29.6 96 mir-96 40.0 33
mir-222 29.8 146 mir-122a 40.0 3
mir-98 29.9 4 mir-135a 40.0 2
mir-30a-3p 30.1 50 mir-105 40.0 13
mir-15a 30.3 187 mir-190 40.0 5
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these small RNAs in regulatory networks and human
diseases (for recent reviews see (2,53–55). In light of the
growing list of characterized miRNAs and claims
of thousands of putative miRNAs, we have developed a
novel ﬂexible microarray that takes advantage of the
highly sensitive ER microarrays, in combination with
the favorable biophysical properties of chemically mod-
iﬁed 20-MOE oligonucleotides as capture probes for
natural RNA. In accordance with data published by
others (25), we found that discrimination between
miRNAs diﬀering by only one or two nucleotides at
the end-proximal positions is diﬃcult due to cross-
hybridization as exempliﬁed by the analysis of let-7
family members (Supplementary Table S5). The let-7
family represents the most challenging set of highly
related sequences which to our knowledge has so far
not been completely resolved by any array-based method-
ology. Although carefully designed mismatch probes used
in the described array platform helped to minimize this
Figure 3. The MOE-ER array proﬁling of miRNAs in eight diﬀerent mouse tissues reveals novel miRNA expression signatures. A selection of
miRNAs displaying tissue-enriched expression patterns is shown. Colors depict relative intensities of array hybridization signals: High (red), medium
(black), low (gray). Quantiﬁcation of expression of all individual miRNA is presented in Supplementary Table S2. He: HeLa; B: brain; H: heart;
I: small intestine; K: kidney; Li: liver; Lu: lung; M: skeletal muscle; S: spleen. Data was clustered to represent tissue-enriched distribution of
expression.
e52 Nucleic Acids Research, 2007, Vol. 35, No. 7 PAGE8 OF11Figure 4. Comparison of the relative abundance of miRNAs determined using MOE-ER array, Northern blot and stem-loop RT-PCR analyses
of human HeLa cell and mouse tissue RNAs. He: HeLa; B: brain; H: heart; I: small intestine; K: kidney; Li: liver; Lu: lung; M: skeletal muscle;
S: spleen.
PAGE 9 OF 11 Nucleic Acids Research, 2007, Vol. 35, No. 7 e52limitation, our present study also suggests that interpreta-
tion of miRNA array data should be cautious until
complemented by the use of other technologies such as
Northern blot and RT-PCR analysis. In the present study,
miRNA array proﬁling data has been systematically
conﬁrmed using such complementary methodologies, at
the same time validating the reliability of the MOE-ER-
array approach. Taken together, the array described here
revealed novel expression signatures for known and novel
computationally predicted miRNAs. This tool will be
valuable in future studies to facilitate analysis of the
biological function of miRNAs.
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